1 |
Potentially Harmful Drug–Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study |
|
|
| Abdulrahman Kalash, Aly Abdelrahman, Ibrahim Al-Zakwani, Yousuf Al Suleimani |
|
| Drugs - Real World Outcomes. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Assessment of Potential Drug-drug Interactions (pDDIs) and Their Risk Factors Among Hospitalized Cardiac Patients in a Tertiary-care Center of Central India: A Retrospective Record-based Study |
|
|
| Ajaya Kumar Sahoo, Alok Singh, Dhyuti Gupta, Suryaprakash Dhaneria, Prachi Arunima |
|
| Hospital Pharmacy. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study |
|
|
| Birbirsa Sefera, Mestawet Getachew, Yadeta Babu, Firomsa Bekele, Korinan Fanta |
|
| BMC Cardiovascular Disorders. 2022; 22(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda |
|
|
| Efrata Ashuro Shegena, Konjit Abebe Nigussie, Robert Tamukong, Boniface Amanee Elias Lumori, Tadele Mekuriya Yadesa |
|
| BMC Cardiovascular Disorders. 2022; 22(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience |
|
|
| Dejan Z. Aleksic, Miloš N. Milosavljevic, Slobodan M. Jankovic, Ana D. Azanjac Arsic, Srdjan M. Stefanovic |
|
| Brazilian Journal of Pharmaceutical Sciences. 2022; 58 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Reintroduction of Post-Baccalaureate Doctor of Pharmacy (PharmD, Post-Bac) Program in Nepal: Exploration of the Obstacles and Solutions to Move Forward |
|
|
| Sunil Shrestha, Sweta Shrestha, Binaya Sapkota, Rajani Shakya, Rohullah Roien, Mohamed Izham Mohamed Ibrahim |
|
| Advances in Medical Education and Practice. 2022; Volume 13: 159 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Data Sharing and Privacy in Pharmaceutical Studies |
|
|
| Rufan Chen, Yi Zhang, Zuochao Dou, Feng Chen, Kang Xie, Shuang Wang |
|
| Current Pharmaceutical Design. 2021; 27(7): 911 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
A PROSPECTIVE OBSERVATIONAL STUDY ON THE ASSESSMENT OF POTENTIAL DRUG-DRUG INTERACTIONS AND MANAGEMENT OF POST-COMPLICATIONS IN STROKE PATIENTS AT A TERTIARY CARE TEACHING HOSPITAL |
|
|
| MAHE NAAZ SULTANA, SABA YOUNUS QURESHI, IQRA FATIMA, WAJIDA JABEEN, MOHAMMED OBAID |
|
| International Journal of Pharmacy and Pharmaceutical Sciences. 2021; : 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study |
|
|
| Zarka Akbar, Sundas Rehman, Asad Khan, Amjad Khan, Muhammad Atif, Nafees Ahmad |
|
| Journal of Pharmaceutical Policy and Practice. 2021; 14(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Prevalence and characteristics of drug-drug interactions among hospitalised patients in the Capital Region of Denmark |
|
|
| Hans Kristian Råket Pedersen, Anne Mette Skov Sørensen, Astrid Blicher Schelde, Martin Erik Nyeland, Espen Jimenez-Solem |
|
| Adverse Drug Reaction Bulletin. 2021; Publish Ah |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals |
|
|
| Abdullah K. Rabba, Ayeshe M. Abu Hussein, Bayan K. Abu Sbeih, Somaya I. Nasser |
|
| BioMed Research International. 2020; 2020: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency |
|
|
| Pengqiang Du, Aifeng Wang, Yongcheng Ma, Ao Jia, Yafei Li, Xingang Li |
|
| Clinical Therapeutics. 2020; 42(9): 1799 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases |
|
|
| Natália da Palma Sobrinho, Juliana Faria Campos, Rafael Celestino da Silva |
|
| Revista Brasileira de Enfermagem. 2020; 73(5) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin |
|
|
| Aurel C.E. Allabi, Yessoufou Tchabi, Murielle Hounkponou, Rebecca Quenum, Jeanne Vehounkpe-Sacca |
|
| Current Drug Safety. 2020; 15(3): 190 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Clinical Pharmacy Education and Practice in Nepal: A Glimpse into Present Challenges and Potential Solutions |
|
|
| Sunil Shrestha, Deepa Shakya, Subish Palaian |
|
| Advances in Medical Education and Practice. 2020; Volume 11: 541 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients |
|
|
| Ghulam Murtaza,Muhammad Yasir Ghani Khan,Saira Azhar,Shujaat Ali Khan,Tahir M. Khan |
|
| Saudi Pharmaceutical Journal. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|